NCT02170896View on ClinicalTrials.gov

Bioavailability of BIBR 963 ZW After 50 mg of BIBR 1048 MS With and Without of Pantoprazole in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

December 31, 2001

Conditions
Healthy
Interventions
DRUG

BIBR 1048 MS Capsule A

DRUG

BIBR 1048 MS Capsule B

DRUG

BIBR 1048 MS Capsule C

DRUG

BIBR 1048 MS Capsule D

DRUG

BIBR 1048 MS tartaric acid solution

DRUG

Pantoprazole

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02170896 - Bioavailability of BIBR 963 ZW After 50 mg of BIBR 1048 MS With and Without of Pantoprazole in Healthy Subjects | Biotech Hunter | Biotech Hunter